A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

July 3, 2026 updated by: AstraZeneca
The purpose of this study is to identify and characterize patients with known Type 2 Diabetes Mellitus (T2DM) for possible participation in ongoing or future T2DM clinical studies, and to characterize trends in key concomitant medication use in this patient population across different geographical regions.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

2150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Brazil
      • Barretos, Brazil, 14784-400
        • Not yet recruiting
        • Research Site
      • Brasília, Brazil, 71625-009
        • Not yet recruiting
        • Research Site
      • Rio de Janeiro, Brazil, 22270-060
        • Not yet recruiting
        • Research Site
    • Ceará
      • Fortaleza, Ceará, Brazil, 60430-350
        • Not yet recruiting
        • Research Site
    • Paraná
      • Curitiba, Paraná, Brazil, 80030-480
        • Not yet recruiting
        • Research Site
    • Rio Grande do Norte
      • Natal, Rio Grande do Norte, Brazil, 59020-035
        • Not yet recruiting
        • Research Site
    • Rio Grande do Sul
      • Porto Alegre, Rio Grande do Sul, Brazil, 90630-165
        • Not yet recruiting
        • Research Site
    • S O Paulo
      • Campinas, S O Paulo, Brazil, 13060-904
        • Not yet recruiting
        • Research Site
      • São José dos Campos, S O Paulo, Brazil, 12243-280
        • Not yet recruiting
        • Research Site
    • São Paulo
      • São Paulo, São Paulo, Brazil, 01228-200
        • Not yet recruiting
        • Research Site
      • São Paulo, São Paulo, Brazil, 04012-180
        • Not yet recruiting
        • Research Site
  • Hungary
      • Budapest, Hungary, 1138
        • Not yet recruiting
        • Research Site
      • Budapest, Hungary, 1132
        • Recruiting
        • Research Site
      • Budapest, Hungary, 1024
        • Recruiting
        • Research Site
      • Salgótarján, Hungary, 3100
        • Not yet recruiting
        • Research Site
      • Szolnok, Hungary, 5000
        • Not yet recruiting
        • Research Site
      • Zalaegerszeg, Hungary, 8900
        • Not yet recruiting
        • Research Site
    • HU
      • Budapest, HU, Hungary, 1036
        • Not yet recruiting
        • Research Site
      • Budapest, HU, Hungary, 1089
        • Not yet recruiting
        • Research Site
      • Debrecen, HU, Hungary, 4032
        • Not yet recruiting
        • Research Site
      • Szeged, HU, Hungary, 6725
        • Not yet recruiting
        • Research Site
  • India
    • Andhra Pradesh
      • Guntur, Andhra Pradesh, India, 522001
        • Not yet recruiting
        • Research Site
    • Assam
      • Guwahati, Assam, India, 781032
        • Not yet recruiting
        • Research Site
    • Karnataka
      • Bangalore, Karnataka, India, 560092
        • Not yet recruiting
        • Research Site
      • Belagavi, Karnataka, India, 590006
        • Not yet recruiting
        • Research Site
      • Belagavi, Karnataka, India, 590010
        • Not yet recruiting
        • Research Site
    • Kerala
      • Calicut, Kerala, India, 673008
        • Not yet recruiting
        • Research Site
      • Kochi, Kerala, India, 682041
        • Not yet recruiting
        • Research Site
      • Thiruvananthapuram, Kerala, India, 695031
        • Not yet recruiting
        • Research Site
    • Madhya Pradesh
      • Indore, Madhya Pradesh, India, 452008
        • Not yet recruiting
        • Research Site
    • Maharashtra
      • Mumbai, Maharashtra, India, 400012
        • Not yet recruiting
        • Research Site
      • Nagpur, Maharashtra, India, 440010
        • Not yet recruiting
        • Research Site
      • Pune, Maharashtra, India, 411013
        • Not yet recruiting
        • Research Site
      • Pune, Maharashtra, India, 411021
        • Not yet recruiting
        • Research Site
    • New Delhi
      • Delhi, New Delhi, India, 110029
        • Not yet recruiting
        • Research Site
    • Rajasthan
      • Jaipur, Rajasthan, India, 302017
        • Not yet recruiting
        • Research Site
    • Tamil Nadu
      • Chennai, Tamil Nadu, India, 600086
        • Not yet recruiting
        • Research Site
      • Coimbatore, Tamil Nadu, India, 641018
        • Not yet recruiting
        • Research Site
    • Uttar Pradesh
      • Lucknow, Uttar Pradesh, India, 226030
        • Not yet recruiting
        • Research Site
    • West Bengal
      • Kolkata, West Bengal, India, 700020
        • Not yet recruiting
        • Research Site
  • Malaysia
      • Putrajaya, Malaysia, 62250
        • Not yet recruiting
        • Research Site
    • Negeri Sembilan
      • Seremban, Negeri Sembilan, Malaysia, 70300
        • Not yet recruiting
        • Research Site
    • Perak
      • Seri Manjung, Perak, Malaysia, 32040
        • Not yet recruiting
        • Research Site
    • Selangor
      • Batu Caves, Selangor, Malaysia, 68100
        • Not yet recruiting
        • Research Site
    • Wilayah Persekutuan Kuala Lump
      • Kuala Lumpur, Wilayah Persekutuan Kuala Lump, Malaysia, 59100
        • Not yet recruiting
        • Research Site
  • Poland
      • Poznnn, Poland, 60-354
        • Active, not recruiting
        • Research Site
      • Warsaw, Poland, 00-124
        • Not yet recruiting
        • Research Site
    • L Dzkie
      • L Dz, L Dzkie, Poland, 90-338
        • Active, not recruiting
        • Research Site
    • Lublin Voivodeship
      • Lublin, Lublin Voivodeship, Poland, 20-718
        • Not yet recruiting
        • Research Site
    • Malopolska
      • Krakow, Malopolska, Poland, 31-261
        • Not yet recruiting
        • Research Site
    • Masovian Voivodeship
      • Radom, Masovian Voivodeship, Poland, 26-600
        • Not yet recruiting
        • Research Site
    • Podlaskie Voivodeship
      • Bialystok, Podlaskie Voivodeship, Poland, 15-879
        • Recruiting
        • Research Site
    • Silesian Voivodeship
      • Częstochowa, Silesian Voivodeship, Poland, 42-217
        • Not yet recruiting
        • Research Site
    • Świętokrzyskie Voivodeship
      • Kielce, Świętokrzyskie Voivodeship, Poland, 25-355
        • Not yet recruiting
        • Research Site
  • Turkey (Türkiye)
      • Adana, Turkey (Türkiye), 01060
        • Not yet recruiting
        • Research Site
      • Adana, Turkey (Türkiye), 01250
        • Not yet recruiting
        • Research Site
      • Ankara, Turkey (Türkiye), 06530
        • Not yet recruiting
        • Research Site
      • Gaziantep, Turkey (Türkiye), 27470
        • Not yet recruiting
        • Research Site
      • Istanbul, Turkey (Türkiye), 34384
        • Not yet recruiting
        • Research Site
      • Istanbul, Turkey (Türkiye), 34265
        • Not yet recruiting
        • Research Site
      • Kayseri, Turkey (Türkiye), 38039
        • Not yet recruiting
        • Research Site
    • Turkey
      • Ankara, Turkey, Turkey (Türkiye), 6100
        • Not yet recruiting
        • Research Site
  • United States
    • Arkansas
      • Little Rock, Arkansas, United States, 72205
        • Not yet recruiting
        • Research Site
    • California
      • Lincoln, California, United States, 95648
        • Recruiting
        • Research Site
    • Florida
      • Lake City, Florida, United States, 32055
        • Not yet recruiting
        • Research Site
      • Ocoee, Florida, United States, 34761
        • Recruiting
        • Research Site
    • Georgia
      • Decatur, Georgia, United States, 30030
        • Recruiting
        • Research Site
    • Kansas
      • El Dorado, Kansas, United States, 67042
        • Not yet recruiting
        • Research Site
    • Maryland
      • Potomac, Maryland, United States, 20854
        • Recruiting
        • Research Site
    • South Carolina
      • Gaffney, South Carolina, United States, 29340
        • Active, not recruiting
        • Research Site
    • Washington
      • Renton, Washington, United States, 98057
        • Not yet recruiting
        • Research Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adults with Type 2 Diabetes

Description

Inclusion Criteria:

  • Participants must be ≥ 18 years of age at the time of signing the ICF.
  • Patients with a diagnosis of T2DM, test- or documentation-confirmed as per World

Health Organization or local diagnostic standards, inadequately managed with:

  1. Lifestyle management alone, AND/OR

  2. A stable dose of background glucose-lowering medication(s) for T2DM (As specified in the Protocol) for at least 45 days prior to signing the ICF.

    • Expresses interest in participating in an ongoing or future T2DM clinical study, is motivated and willing to make themselves available for the duration of the study, and is able to follow study procedures as required.
    • Provision of signed and dated written informed consent (As specified in the Protocol) before any study-specific procedures, sampling, or analysis.

Exclusion Criteria:

  • Current or planned use of GLP-1 RAs prohibited in ongoing or future T2DM studies evaluating the efficacy and safety of investigational GLP-1 RAs (As specified in the Protocol).
  • Diagnosed with Type 1 diabetes mellitus.
  • Known pregnancy at the time of visit or having the intention to become pregnant.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Participants with Type 2 Diabetes
Other: Procedure: assessment
The approximate volume of blood required is 2 mL

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient demographics
Time Frame: Visit 1 (Single day)
Summary statistics
Visit 1 (Single day)
Medical and surgical history
Time Frame: Visit 1 (Single day)
Summary statistics
Visit 1 (Single day)
Concomitant medication
Time Frame: Visit 1 (Single day)
Summary statistics
Visit 1 (Single day)
HbA1c levels
Time Frame: Visit 1 (Single day)
Summary statistics
Visit 1 (Single day)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Referral to ongoing or future T2DM study.
Time Frame: Visit 1 (Single day)
Number of participants with high likelihood of meeting eligibility criteria in ongoing or future T2DM studies, for referral to those studies.
Visit 1 (Single day)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

AstraZeneca

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 6, 2026

Primary Completion (Estimated)

March 31, 2027

Study Completion (Estimated)

March 31, 2027

Study Registration Dates

First Submitted

April 30, 2026

First Submitted That Met QC Criteria

May 20, 2026

First Posted (Actual)

May 26, 2026

Study Record Updates

Last Update Posted (Actual)

July 7, 2026

Last Update Submitted That Met QC Criteria

July 3, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • D7261C00007

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Qualified researchers can request access to anonymized individual patient-level data from AstraZeneca group of companies sponsored clinical trials via the request portal Vivli.org. All requests will be evaluated as per the AZ disclosure commitment: https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.

Yes, indicates that AZ are accepting requests for IPD, but this does not mean all requests will be shared.

IPD Sharing Time Frame

AstraZeneca will meet or exceed data availability as per the commitments made to the EFPIA PhRMA Data Sharing Principles. For details of our timelines, please rerefer to our disclosure commitment at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.

IPD Sharing Access Criteria

When a request has been approved AstraZeneca will provide access to the anonymized individual patient-level data via secure research environment Vivli.org. Signed Data Usage Agreement (non-negotiable contract for data accessors) must be in place before accessing requested information.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 2 Diabetes

Clinical Trials on Procedure: assessment

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe